» Articles » PMID: 29740794

Focal Segmental Glomerulosclerosis with Heterozygous Apolipoprotein E5 (Glu3Lys)

Overview
Journal CEN Case Rep
Specialty Nephrology
Date 2018 May 10
PMID 29740794
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Apolipoprotein (apo) E5 is a rare apoE isoform. The apoE5 (Glu3Lys) variant, which is caused by the substitution of lysine with glutamic acid at codon 3, has a relative frequency of 0.1% in Japan. Previous studies have reported that apoE5 (Glu3Lys) is associated with hyperlipidemia and cardiovascular diseases, but this isoform has higher LDL receptor-binding activity than that of normal apoE3. Nephropathy associated with apoE5 (Glu3Lys) alone has not yet been reported. We present a case of a 51-year-old man with nephrotic syndrome. On renal biopsy, three glomeruli showed segmental sclerosis with hypertrophy of podocytes and intracapillary marked infiltration of intraglomerular foam cells. These findings were compatible with focal segmental glomerulosclerosis (FSGS). The patient had mild diabetes mellitus and monoclonal gammopathy of undetermined significance, but there were no specific findings of nephrolopathy related to these diseases. Various factors are involved in the pathogenesis of FSGS, including dyslipidemia and apoE activity. Our findings suggest that abnormal lipid metabolism by ApoE5 (Glu3Lys) is involved in the onset of FSGS.

Citing Articles

Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis.

Chhuon C, Herrera-Marcos L, Zhang S, Charriere-Bertrand C, Jung V, Lipecka J Int J Mol Sci. 2023; 24(15).

PMID: 37569500 PMC: 10418338. DOI: 10.3390/ijms241512124.


An Updated Review and Meta Analysis of Lipoprotein Glomerulopathy.

Li M, Li Y, Liu Y, Zhou X, Zhang H Front Med (Lausanne). 2022; 9:905007.

PMID: 35602473 PMC: 9120586. DOI: 10.3389/fmed.2022.905007.


Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities.

Lin P, Duann P Front Physiol. 2020; 11:1050.

PMID: 33013450 PMC: 7494972. DOI: 10.3389/fphys.2020.01050.


Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.

Zhong J, Whitman J, Yang H, Fogo A J Histochem Cytochem. 2019; 67(9):623-632.

PMID: 31116068 PMC: 6713971. DOI: 10.1369/0022155419850170.

References
1.
Dong L, Yamamura T, Tajima S, Yamamoto A . Site-directed mutagenesis of an apolipoprotein E mutant, apo E5(Glu3----Lys) and its binding to low density lipoprotein receptors. Biochem Biophys Res Commun. 1992; 187(2):1180-6. DOI: 10.1016/0006-291x(92)91321-g. View

2.
Saito T, Matsunaga A, Oikawa S . Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Am J Kidney Dis. 2006; 47(2):199-211. DOI: 10.1053/j.ajkd.2005.10.017. View

3.
Bruschi M, Catarsi P, Candiano G, Rastaldi M, Musante L, Scolari F . Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Kidney Int. 2003; 63(2):686-95. DOI: 10.1046/j.1523-1755.2003.00777.x. View

4.
Diamond J, Karnovsky M . Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int. 1988; 33(5):917-24. DOI: 10.1038/ki.1988.87. View

5.
Meyrier A . Mechanisms of disease: focal segmental glomerulosclerosis. Nat Clin Pract Nephrol. 2006; 1(1):44-54. DOI: 10.1038/ncpneph0025. View